Results 161 to 170 of about 212,972 (317)

Intranasal Seletracetam in a Patient with Reading Epilepsy: First‐in‐Human Use to Prevent Reflex Seizures

Annals of Neurology, EarlyView.
We report the first human use of intranasal seletracetam (SEL) to prevent reflex seizures. A patient with epilepsy with reading‐induced seizures on levetiracetam (3,000 mg/day) continued to experience reading‐induced focal seizures with preserved consciousness.
Matthias J. Koepp, Kai‐Nicolas Poppert, Thomas Felder, Aljoscha Thomschewski, Sandra Lafenthaler, Pavel Klein, Alexander Rotenberg, Wolfgang Löscher, Chris Rundfeldt, Eugen Trinka   +9 more
wiley   +1 more source

Laser Soldering with a Biosolder for Oral Mucosa Wound Closure in an Experiment. [PDF]

Sovrem Tekhnologii Med
Morozova EA, Sorokina EA, Gerasimenko AY, Ryabkin DI, Suchkova VV, Timakova AA, Fayzullin AL, Tarasenko SV.   +7 more
europepmc   +1 more source

A Case of Oral Mucosa Pigmentation Diagnosed as an Amalgam Tattoo

, 2012
Yoshitaka Takanashi, Hiroshi Hidaka, Toshimitsu Kobayashi   +2 more
openalex   +1 more source

Úlcera eosinófila de la mucosa oral [PDF]

, 2009
A.C. Bencini, Chiara Bencini, V. Strada, M. Florencia Soldavini, Giancarlo Bruno, M.F. Cordeu, M.A. Cotignola   +6 more
openalex   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Targeting the Oral Mucosa: Emerging Drug Delivery Platforms and the Therapeutic Potential of Glycosaminoglycans. [PDF]

Pharmaceutics
Špiljak B, Somogyi Škoc M, Rezić Meštrović I, Bašić K, Bando I, Šutej I.   +5 more
europepmc   +1 more source

Nanoparticle‐Based Tolerogenic Vaccines: Next‐Generation Strategies for Autoimmune and Allergic Disease Therapies

Angewandte Chemie, EarlyView.
Nanoparticle‐based tolerogenic vaccines harness controlled antigen delivery and immunomodulation to establish tolerance in autoimmunity and allergy. This review outlines how nanoparticle design (size, shape, composition, administration route) influences biodistribution and immune‐cell targeting.
Benjamin E. Nachod, Ajay S. Thatte, Rohan Palanki, Michael J. Mitchell   +3 more
wiley   +1 more source

Oxidized Hyaluronic Acid-Based Sponges: A Promising Biomaterial for Oral Mucosa Lesion Application. [PDF]

Int J Mol Sci
Muñoz-Trejo CA, Chuc-Gamboa MG, Cauich-Rodríguez JV, Vargas-Coronado RF, Escobar-García DM, Pozos-Guillen A, Aguilar-Pérez FJ, Pinzón-Te AL, Zumbardo-Bacelis GA.   +8 more
europepmc   +1 more source

Optimization and Characterization of Aspirin‐ and Ibuprofen‐Loaded Lipid‐Based Nanoparticle Synthesis for Antibacterial Activity and Cytotoxic Effect

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Lipid‐based nanoparticles (LNPs) are favored for drug delivery because of their low toxicity, high biocompatibility, ability to self‐assemble into nanoparticles, and ability to enhance drug bioavailability, thereby improving drug release modulation and pharmacokinetics.
Gulizar Caliskan, Smyrna Ergonul, Zuhal Naz Cansu, Busra Kaplan   +3 more
wiley   +1 more source

Evaluation of immuno-expression of galectin-3 in oral submucous fibrosis and healthy oral mucosa. [PDF]

J Oral Maxillofac Pathol
Sheth H, Shah AK, Phulari RGS, Rathore Y, Vasavada DG, Ojha MR.   +5 more
europepmc   +1 more source